Developing a new class of engineered live bacterial therapeutics to treat human diseases

The role microbes play in human health and the ability of synthetic biology to engineer microbial properties opens up new ways of treating disease. In this perspective, the authors describe the design and development of these living therapeutics.

Guardado en:

Detalles Bibliográficos
Autores principales:	Mark R. Charbonneau, Vincent M. Isabella, Ning Li, Caroline B. Kurtz
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2020
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/26fba4ca08df4eda919a1a6132d74277
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:26fba4ca08df4eda919a1a6132d74277
record_format	dspace
spelling	oai:doaj.org-article:26fba4ca08df4eda919a1a6132d742772021-12-02T15:39:20ZDeveloping a new class of engineered live bacterial therapeutics to treat human diseases10.1038/s41467-020-15508-12041-1723https://doaj.org/article/26fba4ca08df4eda919a1a6132d742772020-04-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-15508-1https://doaj.org/toc/2041-1723The role microbes play in human health and the ability of synthetic biology to engineer microbial properties opens up new ways of treating disease. In this perspective, the authors describe the design and development of these living therapeutics.Mark R. CharbonneauVincent M. IsabellaNing LiCaroline B. KurtzNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Science Q
spellingShingle	Science Q Mark R. Charbonneau Vincent M. Isabella Ning Li Caroline B. Kurtz Developing a new class of engineered live bacterial therapeutics to treat human diseases
description	The role microbes play in human health and the ability of synthetic biology to engineer microbial properties opens up new ways of treating disease. In this perspective, the authors describe the design and development of these living therapeutics.
format	article
author	Mark R. Charbonneau Vincent M. Isabella Ning Li Caroline B. Kurtz
author_facet	Mark R. Charbonneau Vincent M. Isabella Ning Li Caroline B. Kurtz
author_sort	Mark R. Charbonneau
title	Developing a new class of engineered live bacterial therapeutics to treat human diseases
title_short	Developing a new class of engineered live bacterial therapeutics to treat human diseases
title_full	Developing a new class of engineered live bacterial therapeutics to treat human diseases
title_fullStr	Developing a new class of engineered live bacterial therapeutics to treat human diseases
title_full_unstemmed	Developing a new class of engineered live bacterial therapeutics to treat human diseases
title_sort	developing a new class of engineered live bacterial therapeutics to treat human diseases
publisher	Nature Portfolio
publishDate	2020
url	https://doaj.org/article/26fba4ca08df4eda919a1a6132d74277
work_keys_str_mv	AT markrcharbonneau developinganewclassofengineeredlivebacterialtherapeuticstotreathumandiseases AT vincentmisabella developinganewclassofengineeredlivebacterialtherapeuticstotreathumandiseases AT ningli developinganewclassofengineeredlivebacterialtherapeuticstotreathumandiseases AT carolinebkurtz developinganewclassofengineeredlivebacterialtherapeuticstotreathumandiseases
_version_	1718385920432930816

Developing a new class of engineered live bacterial therapeutics to treat human diseases

Ejemplares similares